Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Cutter

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
BMJ (Clinical Research Ed.)|June 13, 2023
Breast cancer mortality in 500 000 women with early invasive breast cancer diagnosed in England, 1993-2015: population based observational cohort studyCarolyn Taylor, Paul McGale, Jake Probert, et al.
International Journal of Radiation Oncology, Biology, Physics|November 11, 2021
Proton Therapy in Supradiaphragmatic Lymphoma: Predicting Treatment-Related Mortality to Help Optimize Patient SelectionGeorgios Ntentas, Katerina Dedeckova, Michal Andrlik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 13, 2021
Predicted Risks of Cardiovascular Disease Following Chemotherapy and Radiotherapy in the UK NCRI RAPID Trial of Positron Emission Tomography-Directed Therapy for Early-Stage Hodgkin LymphomaDavid J Cutter, Johanna Ramroth, Patricia Diez, et al.
British Journal of Haematology|November 7, 2024
Assessment of fitness for bleomycin use and management of bleomycin pulmonary toxicity in patients with classical Hodgkin lymphoma: A British Society for Haematology Good Practice PaperAisling Barrett, Nimish Shah, Andrew Chadwick, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 5, 2020
Dose-response relationships for radiation-related heart disease: Impact of uncertainties in cardiac dose reconstructionGeorgios Ntentas, Sarah C Darby, Marianne C Aznar, et al.
British Journal of Cancer|October 25, 2017
Risk stratification of childhood cancer survivors necessary for evidence-based clinical long-term follow-upClare Frobisher, Adam Glaser, Gill A Levitt, et al.
Journal of the National Cancer Institute|February 26, 2015
Risk of valvular heart disease after treatment for Hodgkin lymphomaDavid J Cutter, Michael Schaapveld, Sarah C Darby, et al.
British Journal of Haematology|November 27, 2024
Inequalities in geographic barriers and patient representation in lymphoma clinical trials across EnglandDavid A Jones, Katie Spencer, Johanna Ramroth, et al.
Practical Radiation Oncology|January 29, 2019
Cardiac Structure Doses in Women Irradiated for Breast Cancer in the Past and Their Use in Epidemiological StudiesFrances K Duane, Paul McGale, Dorthe Brønnum, et al.
British Journal of Haematology|February 22, 2022
Guideline for the first-line management of Classical Hodgkin Lymphoma - A British Society for Haematology guidelineGeorge A Follows, Sally F Barrington, Kaljit S Bhuller, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
BMJ (Clinical Research Ed.)|June 13, 2023
Breast cancer mortality in 500 000 women with early invasive breast cancer diagnosed in England, 1993-2015: population based observational cohort studyCarolyn Taylor, Paul McGale, Jake Probert, et al.
International Journal of Radiation Oncology, Biology, Physics|November 11, 2021
Proton Therapy in Supradiaphragmatic Lymphoma: Predicting Treatment-Related Mortality to Help Optimize Patient SelectionGeorgios Ntentas, Katerina Dedeckova, Michal Andrlik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 13, 2021
Predicted Risks of Cardiovascular Disease Following Chemotherapy and Radiotherapy in the UK NCRI RAPID Trial of Positron Emission Tomography-Directed Therapy for Early-Stage Hodgkin LymphomaDavid J Cutter, Johanna Ramroth, Patricia Diez, et al.
British Journal of Haematology|November 7, 2024
Assessment of fitness for bleomycin use and management of bleomycin pulmonary toxicity in patients with classical Hodgkin lymphoma: A British Society for Haematology Good Practice PaperAisling Barrett, Nimish Shah, Andrew Chadwick, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 5, 2020
Dose-response relationships for radiation-related heart disease: Impact of uncertainties in cardiac dose reconstructionGeorgios Ntentas, Sarah C Darby, Marianne C Aznar, et al.
British Journal of Cancer|October 25, 2017
Risk stratification of childhood cancer survivors necessary for evidence-based clinical long-term follow-upClare Frobisher, Adam Glaser, Gill A Levitt, et al.
Journal of the National Cancer Institute|February 26, 2015
Risk of valvular heart disease after treatment for Hodgkin lymphomaDavid J Cutter, Michael Schaapveld, Sarah C Darby, et al.
British Journal of Haematology|November 27, 2024
Inequalities in geographic barriers and patient representation in lymphoma clinical trials across EnglandDavid A Jones, Katie Spencer, Johanna Ramroth, et al.
Practical Radiation Oncology|January 29, 2019
Cardiac Structure Doses in Women Irradiated for Breast Cancer in the Past and Their Use in Epidemiological StudiesFrances K Duane, Paul McGale, Dorthe Brønnum, et al.
British Journal of Haematology|February 22, 2022
Guideline for the first-line management of Classical Hodgkin Lymphoma - A British Society for Haematology guidelineGeorge A Follows, Sally F Barrington, Kaljit S Bhuller, et al.
Pageof 3